JP2019530719A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019530719A5 JP2019530719A5 JP2019520040A JP2019520040A JP2019530719A5 JP 2019530719 A5 JP2019530719 A5 JP 2019530719A5 JP 2019520040 A JP2019520040 A JP 2019520040A JP 2019520040 A JP2019520040 A JP 2019520040A JP 2019530719 A5 JP2019530719 A5 JP 2019530719A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- wavelength
- measured
- temperature
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662408358P | 2016-10-14 | 2016-10-14 | |
| US62/408,358 | 2016-10-14 | ||
| PCT/IB2017/056379 WO2018069892A1 (en) | 2016-10-14 | 2017-10-13 | Crystalline forms of 4-(2-((1r,2r)-2-hydroxycyclohexylamino) benzothiazol-6-yloxy)-n-methylpicolinamide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019530719A JP2019530719A (ja) | 2019-10-24 |
| JP2019530719A5 true JP2019530719A5 (enExample) | 2020-11-19 |
| JP7068288B2 JP7068288B2 (ja) | 2022-05-16 |
Family
ID=60320932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520040A Expired - Fee Related JP7068288B2 (ja) | 2016-10-14 | 2017-10-13 | ４－（２－（（１ｒ，２ｒ）－２－ヒドロキシシクロヘキシルアミノ）ベンゾチアゾール－６－イルオキシ）－ｎ－メチルピコリンアミドの結晶形 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10934273B2 (enExample) |
| EP (1) | EP3526217B1 (enExample) |
| JP (1) | JP7068288B2 (enExample) |
| KR (1) | KR20190064589A (enExample) |
| CN (1) | CN109843880B (enExample) |
| AU (1) | AU2017342239B2 (enExample) |
| BR (1) | BR112019006914A2 (enExample) |
| CA (1) | CA3039764A1 (enExample) |
| CL (1) | CL2019001008A1 (enExample) |
| ES (1) | ES2949414T3 (enExample) |
| IL (1) | IL265893A (enExample) |
| MX (1) | MX2019004345A (enExample) |
| RU (1) | RU2019114208A (enExample) |
| WO (1) | WO2018069892A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
| KR20220130698A (ko) * | 2019-12-20 | 2022-09-27 | 에피자임, 인코포레이티드 | Ezh2 억제제의 결정질 하이드로브로마이드 염, 이의 제조 및 암의 치료에 유용한 약학적 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2649288C (en) * | 2006-04-19 | 2015-11-24 | Novartis Ag | 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| CN101432281B (zh) * | 2006-04-19 | 2013-08-28 | 诺瓦提斯公司 | 6-0-取代的苯并*唑和苯并噻唑化合物以及抑制csf-1r信号传导的方法 |
| KR101938431B1 (ko) * | 2011-05-05 | 2019-01-14 | 노파르티스 아게 | 뇌 종양의 치료를 위한 csf-1r 억제제 |
| EP3233918A1 (en) * | 2014-12-19 | 2017-10-25 | Novartis AG | Combination therapies |
-
2017
- 2017-10-13 US US16/341,124 patent/US10934273B2/en active Active
- 2017-10-13 KR KR1020197010527A patent/KR20190064589A/ko not_active Ceased
- 2017-10-13 AU AU2017342239A patent/AU2017342239B2/en not_active Ceased
- 2017-10-13 CN CN201780063254.XA patent/CN109843880B/zh active Active
- 2017-10-13 JP JP2019520040A patent/JP7068288B2/ja not_active Expired - Fee Related
- 2017-10-13 CA CA3039764A patent/CA3039764A1/en not_active Abandoned
- 2017-10-13 WO PCT/IB2017/056379 patent/WO2018069892A1/en not_active Ceased
- 2017-10-13 RU RU2019114208A patent/RU2019114208A/ru not_active Application Discontinuation
- 2017-10-13 MX MX2019004345A patent/MX2019004345A/es unknown
- 2017-10-13 BR BR112019006914A patent/BR112019006914A2/pt not_active IP Right Cessation
- 2017-10-13 EP EP17797745.1A patent/EP3526217B1/en active Active
- 2017-10-13 ES ES17797745T patent/ES2949414T3/es active Active
-
2019
- 2019-04-07 IL IL265893A patent/IL265893A/en unknown
- 2019-04-12 CL CL2019001008A patent/CL2019001008A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525470A5 (enExample) | ||
| JP2016503010A5 (enExample) | ||
| NZ627750A (en) | Carbamate compounds and of making and using same | |
| JP2017527578A5 (enExample) | ||
| JP4477097B2 (ja) | 中枢神経系障害の治療のための（２ｓ）−（４ｅ）−ｎ−メチル−５−［３−（５−イソプロポキシピリジン）イル］−４−ペンテン−２−アミンの多形形態 | |
| JP2012509321A5 (enExample) | ||
| JP2018516883A5 (enExample) | ||
| JP2022543155A5 (enExample) | ||
| JP2022037122A (ja) | ３－（イミダゾ［１，２－ｂ］ピリダジン－３－イルエチニル）－４－メチル－Ｎ－｛４－［（４－メチルピペラジン－１－イル）メチル］－３－（トリフルオロメチル）フェニル｝ベンズアミドおよびその一塩酸塩の結晶形 | |
| JP6391436B2 (ja) | 固形医薬組成物 | |
| JP5700740B1 (ja) | 固形医薬組成物 | |
| JPWO2014157612A1 (ja) | （１ｓ，４ｓ，５ｓ）−４−ブロモ−６−オキサビシクロ［３．２．１］オクタン−７−オンの製造方法 | |
| JP2012533550A5 (enExample) | ||
| JP2018531280A5 (enExample) | ||
| JP2012532125A5 (enExample) | ||
| JP2019530719A5 (enExample) | ||
| JP2016537326A5 (enExample) | ||
| JP2022540922A5 (enExample) | ||
| EP3717473A1 (en) | Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production | |
| JP2018516946A5 (enExample) | ||
| JP2022535870A (ja) | Ｃｄｋ９阻害剤の結晶多形体及びその製造方法と用途 | |
| TW201638090A (zh) | 一種週期素依賴性蛋白激酶抑制劑的結晶形式及其製備方法 | |
| JP2017507980A5 (enExample) | ||
| CA3074831A1 (en) | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide | |
| RU2019114208A (ru) | Кристаллические формы 4-(2-((1r,2r)-2-гидроксициклогексиламино)бензотиазол-6-илокси)-n-метилпиколинамида |